Recently, RIOK2 has been shown to be involved in tumor migration, invasion, and epithelial-mesenchymal transition through the AKT/mechanistic target of rapamycin kinase signaling pathway in glioblastoma and non-small cell lung cancer9; 10. This evidence concerns the gene MTOR and neoplasm.